All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 2

HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025

Lobbying activity 3

Health Issues

Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; H.R. 1262/S. 932 - Give Kids a Chance Act of 2025.

Medicare/Medicaid

Issues related to the One Big Beautiful Bill Act (P.L. 119-21) Section 44301, expanding and clarifying the exclusion for orphan drugs under the Drug Price Negotiation Program.

Trade (domestic/foreign)

Education on global supply chain management in biotechnology.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.